Using Stakeholder Input to Develop a Best Practice Advisory (BPA) to Increase Prescribing of Automated Insulin Delivery (AID) Systems for People With Type 1 Diabetes (PwT1D)
Authors' conclusion
Successful BPA development and implementation requires addressing clinician concerns about workflow and alert fatigue, while aligning with PwT1D and care partners' expectations for the cadence of conversations on AID systems.
Study context
- Population
- PwT1D, their care partners and diabetes clinicians in the T1D Exchange quality improvement (QI) Collaborative (T1DX-QI)56 centers
- Participants
- 38 vs 18
- Comparison
- Pediatric centers vs Adult centers
- Pediatric centersn = 38
- Adult centersn = 18
- Outcome
- Center view that a BPA would be useful for increasing AID use (annual survey)
Methodological detailsmulti-site, quality improvement initiative, electronic surveys, interviews and focus groups, Focus groups: 31 clinicians from 8 T1DX-QI centers (5 pediatric, 3 adult); interviews with 9 adult PwT1D and 10 care partners
- Multi-site
- Quality improvement initiative
- Electronic surveys, interviews and focus groups
- Focus groups: 31 clinicians from 8 T1DX-QI centers (5 pediatric, 3 adult); interviews with 9 adult PwT1D and 10 care partners
Main finding
As reported in the abstract
- PwT1D and care partners: BPA would help remind clinicians to discuss technology
- 96%
- PwT1D and care partners: BPA could help PwT1D use these technologies
- 77%
- Recommended cadence
- every three months
Original publication
Using Stakeholder Input to Develop a Best Practice Advisory (BPA) to Increase Prescribing of Automated Insulin Delivery (AID) Systems for People With Type 1 Diabetes (PwT1D). J Diabetes Sci Technol. Published 7 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →